Case Report: Bullous Lung Disease Following COVID-19

Frontiers in Medicine

Prachi Pednekar¹  Robert Homer²  Kwesi Amoah³  Changwan Ryu⁴  Denyse D. Lutchmansingh⁴ 

[1] Department of Internal Medicine, Bridgeport Hospital, Bridgeport, CT, United States;Department of Pathology, Yale School of Medicine, New Haven, CT, United States;Section of Pulmonary, Critical Care, and Sleep Medicine, Bridgeport Hospital, Bridgeport, CT, United States;Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT, United States;

关键词: COVID-19;    bullous lung disease;    post-acute COVID-19;    SARS CoV-2;    post-COVID “Long Haulers”;   

DOI  :  10.3389/fmed.2021.770778

来源: DOAJ

【 摘 要 】

More than 87% of patients report the persistence of at least one symptom after recovery from the Coronavirus disease 2019 (COVID-19). Dyspnea is one of the most frequently reported symptoms following severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) infection with persistent chest radiological abnormalities up to 3 months after symptom onset. These radiological abnormalities are variable and most commonly include ground-glass opacities, reticulations, mosaic attenuation, parenchymal bands, interlobular septal thickening, bronchiectasis, and fibrotic-like changes. However, in this case report, we describe findings of bullous lung disease as a complication of SARS CoV-2 infection. As the pandemic continues, there is a need to understand the multiple respiratory manifestations of post-acute sequelae of COVID-19. We, therefore, present this case to add to the current body of literature describing pulmonary disease as a consequence of SARS CoV-2 infection.

【 授权许可】

Unknown